Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance

Area of Science:

• Nuclear Medicine
• Renal Physiology
• Diagnostic Imaging

Background:

• Technetium-99m-mercaptoacetyltriglycine (99mTc-MAG3) clearance is a reliable indicator of renal function.
• Previous research established a correlation between 99mTc-MAG3 and orthoiodohippuran (OIH) clearance.
• A pooled analysis of multi-sample clearance data led to a single-sample regression equation for 99mTc-MAG3 clearance estimation.

Purpose of the Study:

• To prospectively validate a previously published single-sample regression equation for estimating 99mTc-MAG3 clearance.
• To assess the accuracy of this equation across a diverse range of renal function levels.

Main Methods:

• A prospective study involving 34 patients with varying renal function.
• Collection of multiple plasma samples between 9 and 60 minutes post-injection of 99mTc-MAG3.
• Calculation of clearance using a two-compartment model and comparison with estimates from the single-sample regression equation (using a 43-min sample).

Main Results:

• An excellent correlation (r = 0.976) was observed between the two clearance measurement methods.
• The regression analysis showed a slope of 1.01 and an intercept of -26.6.
• The standard error of the estimate was 24 ml/min, indicating good precision.

Conclusions:

• The existing regression equation provides a reliable and accurate estimation of 99mTc-MAG3 clearance.
• This validated method simplifies the assessment of renal function using a single plasma sample.
• The findings support the routine clinical use of this simplified method for evaluating kidney function.